All @ statin-nave ACS patients enrolled in the PRATO-ACS ( Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Acute Kidney Injury and Myocardial Damage in ACS Patients ) study were stratified into baseline hs-CRP tertiles : < @ mg/l , @ to < @ mg/l , and @ mg/l .